| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| osimertinib mechanism of action pdf | 0.42 | 0.6 | 2537 | 47 | 35 |
| osimertinib | 1.2 | 0.1 | 7492 | 64 | 11 |
| mechanism | 0.99 | 0.3 | 3341 | 87 | 9 |
| of | 0.86 | 0.2 | 7701 | 64 | 2 |
| action | 0.93 | 0.5 | 1778 | 50 | 6 |
| 0.57 | 0.4 | 1309 | 25 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| osimertinib mechanism of action pdf | 0.92 | 0.7 | 8186 | 12 |
| osimertinib mechanism of action ppt | 0.46 | 0.1 | 8189 | 6 |
| osimertinib mechanism of resistance | 0.37 | 0.8 | 5436 | 17 |
| osimertinib duration of action | 1.27 | 0.4 | 4573 | 50 |
| resistance mechanisms to osimertinib | 1.44 | 0.7 | 4390 | 89 |
| how does osimertinib work | 1.63 | 0.6 | 4832 | 97 |
| osimertinib mecanismo de accion | 1.89 | 0.5 | 3752 | 20 |
| osimertinib time to response | 0.91 | 0.6 | 9558 | 7 |
| osimertinib summary basis of approval | 0.32 | 0.1 | 5457 | 91 |
| osimertinib plasma protein binding | 1.71 | 0.7 | 6029 | 68 |
| primary resistance to osimertinib | 1.18 | 0.1 | 6293 | 80 |
| osimertinib_1919 | 1.52 | 0.1 | 6991 | 74 |
| osimertinib + savolitinib | 1.33 | 0.1 | 6487 | 35 |
| is osimertinib an immunosuppressant | 0.32 | 0.2 | 4528 | 20 |
| what is osimertinib used for | 1.75 | 0.3 | 3762 | 15 |
| is osimertinib a chemotherapy drug | 1.99 | 0.1 | 3897 | 48 |
| osimertinib potential side effect | 1.29 | 0.5 | 8622 | 82 |
| osimertinib side effects macmillan | 0.23 | 1 | 303 | 100 |
| is osimertinib a chemotherapy | 1.02 | 1 | 9656 | 51 |
| osimertinib scheda tecnica aifa | 1.73 | 0.7 | 4469 | 56 |
